Hikma Pharmaceuticals holds the cleaner structural position, with stability as the main driver and valuation adding further support. STERIS still has the edge on stability, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.
The comparison is based on similar long-term financial trajectories, not sector labels. Peer scores are normalised within each company's primary universe (HIK.L: STOXX 600, STE: Russell 1000).
Stability points more clearly toward STERIS plc, even if the broader score still leans toward Hikma Pharmaceuticals PLC.
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.
The match is driven mainly by revenue stability and capital structure.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The clearest separation appears in stability.
Left means cheaper relative valuation. Higher means stronger structure.
Hikma Pharmaceuticals PLC and STERIS plc look relatively close on structure, but the price setup still leans toward Hikma Pharmaceuticals PLC.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
The stability gap is wide, with the stronger side looking materially steadier through time.
STERIS plc still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.
Stability is the clearest driver of the lead, with valuation adding further support — though stability still provides a real counterweight.
Break down the HIK.L vs STE comparison across all dimensions with the full interactive tool.
Explore how HIK.L and STE each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.